01129nas a2200385   4500000000100000000000100001000000100002008004100003653001100044653004200055653006000097653001900157653002300176653004200199653003500241653004700276653007500323653000900398653001100407653001700418653002700435653002900462100001400491700001600505700001800521700001500539700001300554700001400567700001700581245009700598250001500695300001200710490000700722020001400729       2024                            d10aHumans10aAnti-Bacterial Agents/therapeutic use10aAnti-Inflammatory Agents, Non-Steroidal/adverse effects10aCohort Studies10aDrug Prescriptions10a*Infections/drug therapy/epidemiology10aPractice Patterns, Physicians'10a*Respiratory Tract Infections/epidemiology10a*Urinary Tract Infections/drug therapy/epidemiology/chemically induced10aMale10aFemale10aprimary care10aRespiratory infections10aurinary tract infections1 aB. Stuart1 aR. Venekamp1 aH. Hounkpatin1 aS. Wilding1 aM. Moore1 aP. Little1 aM. Gulliford00aNSAID prescribing and adverse outcomes in common infections: a population-based cohort study  a2024/01/04  ae0773650 v14  a2044-6055